Menu ×


Anti Obesity Drugs Market : Global Demand Analysis & Opportunity Outlook 2021

  • Report ID: 23
  • Text Size:


Anti-obesity drugs are used to control body weight either by reducing appetite or absorption of calories. The global anti-obesity drug market is anticipated to grow at compound annual growth rate (CAGR) of 40.0 percent over the period of 2015-2020. Geographically, the global anti-obesity drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific and Rest of World.

Market Size and Forecast

Regionally, North America anti-obesity drug market is forecasted to have a burgeoned growth during the forecast period i.e. 2015-2021. The market is likely to get propelled owing to rising cases of obesity, expanding healthcare industry and various government initiatives to curb obesity problems.

Europe anti-obesity drug market is also expected to witness a steady growth owing to rising cases of diabetes (which is majorly caused due to obesity) in some of the major European countries such as Germany, Spain, Italy, France and the U.K.

Asia-Pacific anti-obesity drug market is anticipated to bolster backed up by improvements in the healthcare sector and increase in disposable income. India and China are two major anti-obesity drug markets in Asia-Pacific region. CLICK TO DOWNLOAD SAMPLE

Growth Drivers and challenges

Prevailed bad eating habits, steep growth in packaged food consumption, less physical activity and hereditary concerns are the biggest factor in the increased obese people. Rising concern of health problems related to obesity, presence of large numbers of obese people around the globe and change in lifestyle are the major growth drivers of global anti-obesity drug market.

Global anti-obesity drug market faces some of major challenges like high cost involved in research and development, side effects of anti-obesity drugs, and rising popularities of other alternatives (fitness spas, therapies, etc.) to reduce obesity.

Market Segmentation

By Product Type

Based on product type, the global anti-obesity drug market divided into two types:

  • Peripherally acting anti-obesity agents
  • Centrally acting anti-obesity drugs

By Type

  • Prescription Drugs
  • Over-the-Counter Drugs

By End User

Based on end user, the global anti-obesity drug market is segmented as:

  • Hospitals
  • Vendors

The study further analysis the Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Key players

The major players of global anti-obesity drug market are mentioned as below:

  • Arena Pharmaceuticals Inc.,
  • F. Hoffmann-La Roche Ag,
  • GlaxoSmithKline plc,
  • Takeda Pharmaceuticals Company Limited,
  • Zafgen,
  • Zydus Cadila,
  • Rhythm Pharmaceuticals,
  • Pfizer Inc.,
  • Merck & Co. Inc.,
  • Orexigen Therapeutics Inc.,
  • Boehringer Ingelheim Gmbh
  • Eisai Co. Ltd.,
  • Novo Nordisk A/S,
  • Norgine B.V.


Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved